Roche Pharma India has launched a subcutaneous Tecentriq injection for eligible lung cancer patients. The shorter dosing time ...

PD-1 and PD-L1 inhibitors are types of immune checkpoint inhibitors, which are immunotherapy medications for treating cancer. Immunotherapy helps the immune system find and kill cancer cells. Some ...

Roche launches Tecentriq SC, a quick lung cancer treatment injection in India, reducing administration time and improving ...

What Is It, and Why Does It Matter? Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in ...

Approved by the Drugs Controller General of India around two months ago for adjuvant and metastatic non-small cell lung ...

The new injection uses a drug called atezolizumab, which works by blocking a protein called PD-L1. Cancer cells use this ...

Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.

Sponsor: Boom Broadcast & Media Relations on behalf of LCFAmerica Lung cancer treatment is undergoing a quiet but meaningful ...

Injections and infusions are a common way to receive chemotherapy. Both methods deliver cancer-treating medications directly into the bloodstream. Chemotherapy is a common cancer treatment that uses ...

India launches a seven-minute lung cancer immunotherapy injection Tecentriq that may improve patient comfort and reduce ...